State Street Corp Nurix Therapeutics, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 2,371,271 shares of NRIX stock, worth $47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,371,271

Previous 2,708,533 12.45%

Holding current value

$47 Million

Previous $56.5 Million 5.82%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$18.93 - $25.69 $6.38 Million - $8.66 Million	-337,262 Reduced 12.45%	2,371,271 $53.2 Million
Q2 2024 Aug 14, 2024	SELL	$12.02 - $21.3 $250,052 - $443,103	-20,803 Reduced 0.76%	2,708,533 $56.5 Million
Q1 2024 May 15, 2024	BUY	$7.77 - $15.66 $14 Million - $28.3 Million	1,808,014 Added 196.24%	2,729,336 $40.1 Million
Q4 2023 Feb 14, 2024	SELL	$4.25 - $10.71 $3.62 Million - $9.13 Million	-852,746 Reduced 48.07%	921,322 $9.51 Million
Q3 2023 Nov 14, 2023	SELL	$7.86 - $10.08 $1.19 Million - $1.53 Million	-151,658 Reduced 7.88%	1,774,068 $13.9 Million
Q2 2023 Aug 14, 2023	SELL	$8.7 - $13.28 $2.69 Million - $4.11 Million	-309,552 Reduced 13.85%	1,925,726 $19.2 Million
Q1 2023 May 15, 2023	SELL	$8.56 - $13.26 $2.33 Million - $3.62 Million	-272,709 Reduced 10.87%	2,235,278 $19.8 Million
Q4 2022 Feb 14, 2023	BUY	$9.86 - $14.59 $1.93 Million - $2.86 Million	195,763 Added 8.47%	2,507,987 $27.5 Million
Q3 2022 Nov 15, 2022	BUY	$12.33 - $19.81 $2.41 Million - $3.87 Million	195,453 Added 9.23%	2,312,224 $30.1 Million
Q2 2022 Aug 15, 2022	SELL	$7.88 - $14.82 $1.46 Million - $2.75 Million	-185,773 Reduced 8.07%	2,116,771 $26.8 Million
Q1 2022 May 16, 2022	BUY	$12.94 - $29.65 $9.64 Million - $22.1 Million	744,832 Added 47.82%	2,302,544 $32.3 Million
Q4 2021 Feb 14, 2022	SELL	$26.43 - $34.5 $1.99 Million - $2.6 Million	-75,419 Reduced 4.62%	1,557,712 $45.1 Million
Q3 2021 Nov 15, 2021	SELL	$22.71 - $36.69 $5.14 Million - $8.3 Million	-226,337 Reduced 12.17%	1,633,131 $48.9 Million
Q2 2021 Aug 16, 2021	BUY	$24.21 - $35.89 $11.7 Million - $17.3 Million	481,606 Added 34.95%	1,859,468 $49.3 Million
Q1 2021 May 17, 2021	BUY	$26.98 - $50.17 $25 Million - $46.5 Million	926,630 Added 205.36%	1,377,862 $42.8 Million
Q4 2020 Feb 16, 2021	BUY	$22.85 - $48.44 $7.3 Million - $15.5 Million	319,559 Added 242.69%	451,232 $14.8 Million
Q3 2020 Nov 10, 2020	BUY	$16.05 - $34.91 $2.11 Million - $4.6 Million	131,673 New	131,673 $4.6 Million

Others Institutions Holding NRIX

# of Institutions

181

Shares Held

68.1M

Call Options Held

78K

Put Options Held

53.8K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $935M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Nurix Therapeutics, Inc. Transaction History